Conduit Pharmaceuticals Inc. (CDT) — Cash Flow Quality Index

Latest as of March 2026: -0.37x

Conduit Pharmaceuticals Inc. (CDT) has a Cash Flow Quality Index of -0.37x as of March 2026. Operating cash flow of $-18.67 Million is below net income of $51.03 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Conduit Pharmaceuticals Inc. assets under control for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.37x
Operating CF / Net Income

Operating Cash Flow

$-18.67 Million
USD

Net Income

$51.03 Million
USD

Data as of

Mar 2026
Most recent filing

Annual Cash Flow Quality Index for Conduit Pharmaceuticals Inc. (None–None)

Year-by-year earnings quality comparison for Conduit Pharmaceuticals Inc.. For live market cap and the full company financial profile, see CDT company net worth.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.